NPPA Retail Price Computation for Diclofenac Sodium Injection

Sep 16, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA), based on February 2026 market data, has computed the retail price under Paragraph 5 of the Drugs (Prices Control) Order, 2013 (DPCO, 2013) for the formulation “Each ml contains: Diclofenac Sodium IP 75 mg”, manufactured by M/s Nichepharm Lifesciences Pvt. Ltd. and marketed by M/s Softdeal Pharmaceutical Pvt. Ltd. The worked-out retail price is ₹29.56 per ml, excluding GST.

The computation is based on the market data considered by NPPA under the applicable pricing methodology, including the average price of the considered formulations and the prescribed 16% retailer margin. The proposed retail price has been determined at ₹29.56 per ml, excluding GST.

Accordingly, the worked-out and proposed retail price is ₹29.56 per ml (excluding GST) for the specified Diclofenac Sodium formulation. The proposal relates to retail price determination under Paragraph 5 of DPCO, 2013 and is identified under File No. 19(5337)/2026/DP/NPPA/Div.II.

[File No. 19(5337)/2026/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

✦ NEW  ·  AI ASSISTANT